Tissue transglutaminase (tTG) belongs to the family of transglutaminase enz
ymes that catalyze the posttranslational modification of proteins via Ca2+-
dependent cross-linking reactions. The catalytic action of tTG results in t
he formation of an isopeptide bond that is of great physiological significa
nce since it is highly resistant to proteolysis and denaturants. Although t
TG-mediated cross-linking reactions have been implicated to play a role in
diverse biological processes, the precise physiological function of the enz
yme remains unclear. Recent data, however, suggest that the protein polymer
s resulting from tTG-catalyzed reactions may pray a role in commitment of c
ells to undergo apoptosis. On the same token, tTG-mediated formation of ins
oluble protein aggregates may underlie the markers of numerous pathological
conditions, such as the senile plaques in Alzheimer's disease and the Lewy
bodies in Parkinson's disease. In addition to catalyzing Ca2+-dependent cr
oss-linking reactions, tTG can also bind and hydrolyze guanosine triphospha
te and adenosine triphosphate. By virtue of this ability, tTG has been iden
tified as a novel G-protein that interacts and activates phospholipase C fo
llowing stimulation of the alpha-adrenergic receptor. The ability of tTG to
mediate signal transduction may contribute to its involvement in the regul
ation of cell cycle progression. The following review summarizes the import
ant features of this multifunctional enzyme that have emerged as a result o
f recent work from different laboratories. (C) 1999 Elsevier Science Ltd. A
ll rights reserved.